- Issuer ticker
-
AVXL
- Reported as of
-
20 Feb 2024
- Net transaction value
-
$0
Source evidence
Original filing metadata and source links for verification.
5 source fields
- SEC form
-
4
- Accepted by SEC
-
23 Feb 2024, 06:03:06 UTC
Reporting owner
1 detail
- Reporting owner signature
-
/s/Athanasios Skarpelos
Key filing fact
Athanasios Skarpelos filed Form 4 for ANAVEX LIFE SCIENCES CORP. (AVXL) on 23 Feb 2024.
Key facts
- This page summarizes Athanasios Skarpelos's Form 4 filing for ANAVEX LIFE SCIENCES CORP. (AVXL).
- 1 reported transaction and 1 derivative row are listed below.
- Accepted by SEC: 23 Feb 2024, 06:03.
Change
- Previous filing in this sequence was filed on 04 Apr 2023.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
Ownership activity is grounded in SEC Form 4 disclosures.
View source filing
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
AVXL
transaction
Derivative
Stock Option (Right to Buy)
Award
- Transaction value
- $0
- Shares
- +50,000
- Change %
- Price
-
$0.000000
- Shares after
- 50,000
- Date
- 20 Feb 2024
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 50,000
- Exercise price
- $5.36
- Footnotes
- F1
* marks a reported price that did not pass the local price check.
Section 16 status
Athanasios Skarpelos is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may still apply in specific circumstances.
Explanation of responses
1 footnote